To The Moon
Home
News
TigerAI
Log In
Sign Up
SSim
+Follow
Posts · 359
Posts · 359
Following · 0
Following · 0
Followers · 0
Followers · 0
SSim
SSim
·
2022-05-13
Like pls
S&P 500 Up 1.9%, Nasdaq Composite Jumps 3%
U.S. stocks gained Friday, shaking off some losses from earlier this week after concerns over persis
S&P 500 Up 1.9%, Nasdaq Composite Jumps 3%
看
2.24K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
SSim
SSim
·
2022-05-04
Like n comment
Want $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years
This dividend stock is one of the few holdings that Cathie Wood and Warren Buffett have in common.
Want $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years
看
2.18K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
SSim
SSim
·
2022-03-11
Like pls
7 Cathie Wood Stocks That Are Worth Buying in March
ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In
7 Cathie Wood Stocks That Are Worth Buying in March
看
2.48K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
SSim
SSim
·
2022-02-11
Like pls
Wall Street Ends down Sharply on Fears of Aggressive Fed Rate Hikes
* CPI rose 7.5% in January, above estimates* Bullard "dramatically" more hawkish* Disney jumps on upbeat quarterly results* Indexes: Dow -1.47%, S&P 500 -1.81%, Nasdaq -2.10%Feb 10 (Reuters) - Wall St
Wall Street Ends down Sharply on Fears of Aggressive Fed Rate Hikes
看
2.46K
回复
Comment
点赞
3
编组 21备份 2
Share
Report
SSim
SSim
·
2022-02-10
Like pls
Want 140% to 225% Gains? 2 Growth Stocks to Buy, According to Wall Street
Despite a difficult macroeconomic environment, some analysts are bullish on these growth stocks.
Want 140% to 225% Gains? 2 Growth Stocks to Buy, According to Wall Street
看
2.50K
回复
Comment
点赞
2
编组 21备份 2
Share
Report
SSim
SSim
·
2022-02-06
Like n comment pls
Sorry, this post has been deleted
看
2.93K
回复
Comment
点赞
5
编组 21备份 2
Share
Report
SSim
SSim
·
2022-01-11
Like pls
10 Biggest Price Target Changes For Tuesday
Keybanc cut the price target for Netflix, Inc. from $725 to $620. Netflix shares rose 0.3% to $541.5
10 Biggest Price Target Changes For Tuesday
看
2.82K
回复
Comment
点赞
6
编组 21备份 2
Share
Report
SSim
SSim
·
2022-01-10
Good news
TSM Q4 Earnings Preview: Q4 Sales Seen Up 21%
Taiwan Semiconductor Manufacturing (TSM), the world's largest chip foundry will report its results f
TSM Q4 Earnings Preview: Q4 Sales Seen Up 21%
看
3.05K
回复
Comment
点赞
7
编组 21备份 2
Share
Report
SSim
SSim
·
2022-01-02
Like pls
2 No-Brainer Stocks Down 27% to 35% to Buy for 2022
These hot tech stocks might be a steal at these prices.
2 No-Brainer Stocks Down 27% to 35% to Buy for 2022
看
3.10K
回复
Comment
点赞
4
编组 21备份 2
Share
Report
SSim
SSim
·
2021-12-24
Like pls
U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea
U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19
看
3.24K
回复
Comment
点赞
1
编组 21备份 2
Share
Report
Load more
Most Discussed
{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3573512309350380","uuid":"3573512309350380","gmtCreate":1610420990768,"gmtModify":1613106626401,"name":"SSim","pinyin":"ssim","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":37,"headSize":595,"tweetSize":359,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-3","templateUuid":"1026c425416b44e0aac28c11a0848493","name":" Tiger Idol","description":"Join the tiger community for 1500 days","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2025.02.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.46%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.55%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.62%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":9067612939,"gmtCreate":1652452726821,"gmtModify":1676535103864,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":" Like pls","listText":" Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9067612939","repostId":"1135375062","repostType":4,"repost":{"id":"1135375062","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1652451049,"share":"https://ttm.financial/m/news/1135375062?lang=&edition=fundamental","pubTime":"2022-05-13 22:10","market":"us","language":"en","title":"S&P 500 Up 1.9%, Nasdaq Composite Jumps 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135375062","media":"Tiger Newspress","summary":"U.S. stocks gained Friday, shaking off some losses from earlier this week after concerns over persis","content":"<html><head></head><body><p>U.S. stocks gained Friday, shaking off some losses from earlier this week after concerns over persistent inflation and the resilience of the U.S. economy stirred up further volatility in recent sessions.</p><p>The Dow Jones Industrial Average rose 408.94 points, or 1.29% to 32,139.</p><p>The S&P 500 was traded higher by 76.07 points, or 1.94%, at 4,006.15, while the Nasdaq Composite gained 335 points, or 2.95%, to 11,706.</p><p><img src=\"https://static.tigerbbs.com/34ca5cda11584fa13698ce4c72a59cb8\" tg-width=\"1080\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/></p><p>Just a day earlier, the S&P 500 had closed within striking distance of a bear market, typically defined as a close of at least 20% from a recent record high. The index has declined by just over 18% from its Jan. 3 record high through Thursday's close, and it paced toward a weekly drop of 4.7% if levels hold through the end of Friday's session.</p><p>The Dow Jones Industrial Average and Nasdaq Composite each also headed for weekly losses of 3.6% and 6.4%, respectively, based on Thursday's closing prices. Treasury yields have spiked and then pared gains back this week, with the benchmark 10-year Treasury yield hovering around 2.9% Friday morning. Bitcoin prices recovered to trade above $30,000 after setting the lowest level since Dec. 2020, as a cratering in prices of Luna further reverberated across the broader cryptocurrency market.</p><p>The market gyrations this week coincided with two major inflation reports that came in hotter-than-expected. Thursday's Producer Price Index showed an 11% year-over-year rise in wholesale prices last month, with this rate moderating only slightly from March's all-time high rate of 11.5%. And the Consumer Price Index released earlier this week showed a still-elevated 8.3% annual increase in prices paid by consumers last month.</p><p>Other strategists agreed that the Fed's response to inflation — and how well the economy holds up as the Fed tightens financial conditions to address inflation — will be the key factor to watch going forward for the markets.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 Up 1.9%, Nasdaq Composite Jumps 3%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 Up 1.9%, Nasdaq Composite Jumps 3%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-05-13 22:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>U.S. stocks gained Friday, shaking off some losses from earlier this week after concerns over persistent inflation and the resilience of the U.S. economy stirred up further volatility in recent sessions.</p><p>The Dow Jones Industrial Average rose 408.94 points, or 1.29% to 32,139.</p><p>The S&P 500 was traded higher by 76.07 points, or 1.94%, at 4,006.15, while the Nasdaq Composite gained 335 points, or 2.95%, to 11,706.</p><p><img src=\"https://static.tigerbbs.com/34ca5cda11584fa13698ce4c72a59cb8\" tg-width=\"1080\" tg-height=\"435\" referrerpolicy=\"no-referrer\"/></p><p>Just a day earlier, the S&P 500 had closed within striking distance of a bear market, typically defined as a close of at least 20% from a recent record high. The index has declined by just over 18% from its Jan. 3 record high through Thursday's close, and it paced toward a weekly drop of 4.7% if levels hold through the end of Friday's session.</p><p>The Dow Jones Industrial Average and Nasdaq Composite each also headed for weekly losses of 3.6% and 6.4%, respectively, based on Thursday's closing prices. Treasury yields have spiked and then pared gains back this week, with the benchmark 10-year Treasury yield hovering around 2.9% Friday morning. Bitcoin prices recovered to trade above $30,000 after setting the lowest level since Dec. 2020, as a cratering in prices of Luna further reverberated across the broader cryptocurrency market.</p><p>The market gyrations this week coincided with two major inflation reports that came in hotter-than-expected. Thursday's Producer Price Index showed an 11% year-over-year rise in wholesale prices last month, with this rate moderating only slightly from March's all-time high rate of 11.5%. And the Consumer Price Index released earlier this week showed a still-elevated 8.3% annual increase in prices paid by consumers last month.</p><p>Other strategists agreed that the Fed's response to inflation — and how well the economy holds up as the Fed tightens financial conditions to address inflation — will be the key factor to watch going forward for the markets.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1135375062","content_text":"U.S. stocks gained Friday, shaking off some losses from earlier this week after concerns over persistent inflation and the resilience of the U.S. economy stirred up further volatility in recent sessions.The Dow Jones Industrial Average rose 408.94 points, or 1.29% to 32,139.The S&P 500 was traded higher by 76.07 points, or 1.94%, at 4,006.15, while the Nasdaq Composite gained 335 points, or 2.95%, to 11,706.Just a day earlier, the S&P 500 had closed within striking distance of a bear market, typically defined as a close of at least 20% from a recent record high. The index has declined by just over 18% from its Jan. 3 record high through Thursday's close, and it paced toward a weekly drop of 4.7% if levels hold through the end of Friday's session.The Dow Jones Industrial Average and Nasdaq Composite each also headed for weekly losses of 3.6% and 6.4%, respectively, based on Thursday's closing prices. Treasury yields have spiked and then pared gains back this week, with the benchmark 10-year Treasury yield hovering around 2.9% Friday morning. Bitcoin prices recovered to trade above $30,000 after setting the lowest level since Dec. 2020, as a cratering in prices of Luna further reverberated across the broader cryptocurrency market.The market gyrations this week coincided with two major inflation reports that came in hotter-than-expected. Thursday's Producer Price Index showed an 11% year-over-year rise in wholesale prices last month, with this rate moderating only slightly from March's all-time high rate of 11.5%. And the Consumer Price Index released earlier this week showed a still-elevated 8.3% annual increase in prices paid by consumers last month.Other strategists agreed that the Fed's response to inflation — and how well the economy holds up as the Fed tightens financial conditions to address inflation — will be the key factor to watch going forward for the markets.","news_type":1,"symbols_score_info":{".SPX":0.9,".IXIC":0.9}},"isVote":1,"tweetType":1,"viewCount":2242,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9061280180,"gmtCreate":1651627907861,"gmtModify":1676534939053,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like n comment","listText":"Like n comment","text":"Like n comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9061280180","repostId":"2231122550","repostType":4,"repost":{"id":"2231122550","kind":"highlight","pubTimestamp":1651626072,"share":"https://ttm.financial/m/news/2231122550?lang=&edition=fundamental","pubTime":"2022-05-04 09:01","market":"us","language":"en","title":"Want $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2231122550","media":"Motley Fool","summary":"This dividend stock is one of the few holdings that Cathie Wood and Warren Buffett have in common.","content":"<div>\n<p>Cathie Wood and Warren Buffett could be thought of as representing different ends of the investing spectrum. Wood has made her name betting on hyper-growth companies with an eye to the future. ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/30/want-2000-passive-income-invest-10000-stock/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $2,000 in Passive Income? Invest $10,000 in This Cathie Wood Dividend Stock and Wait 5 Years\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-04 09:01 GMT+8 <a href=https://www.fool.com/investing/2022/04/30/want-2000-passive-income-invest-10000-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood and Warren Buffett could be thought of as representing different ends of the investing spectrum. Wood has made her name betting on hyper-growth companies with an eye to the future. ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/04/30/want-2000-passive-income-invest-10000-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.fool.com/investing/2022/04/30/want-2000-passive-income-invest-10000-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2231122550","content_text":"Cathie Wood and Warren Buffett could be thought of as representing different ends of the investing spectrum. Wood has made her name betting on hyper-growth companies with an eye to the future. Meanwhile, Buffett is best known as a value-investing guru.As such, it shouldn't come as much of a surprise that Wood's Ark Invest and Buffett's Berkshire Hathaway don't share too many holdings in common. There are some rare exceptions, however. Read on for a look at a healthcare-sector leader backed by Buffett and Wood that pays a substantial dividend and stands out as a worthwhile buy for investors seeking passive income.This pharma giant is broadening its horizonAbbVie is a pharmaceutical company with a current market capitalization of roughly $254 billion. The business is best-known for its Humira drug, which is a monoclonal antibody used to treat rheumatoid arthritis, ulcerative colitis, Crohn's disease, and a variety of other conditions. Humira has been the best-selling drug in the world for most of the last decade; it recorded roughly $17.3 billion in sales for AbbVie last year, and it's helped fuel stellar growth for the company.Image source: AbbVie.While Humira accounted for roughly 31% of the company's sales last year, AbbVie has been diversifying its portfolio in preparation for the rising competition from biosimilars and the eventual expiration of most of the patents on the drug in 2034.Outside of Humira, the company's immunology segment is poised to benefit from ramping sales for its Skyrizi and Rinvoq drugs with expectations that combined sales will grow roughly 226% from 2021 to reach more than $15 billion in 2025. In addition to its core immunology business, the company has products in the hematologic oncology, neurology, and aesthetics categories.The company also has a leading position in the eye-care segment, and it's aiming to continue building on its portfolio for the treatment of glaucoma and dry eye. In addition to these initiatives, the company is gearing up to launch its Vuity drug for the treatment of presbyopia, establish a strong position in the treatment of retinal diseases, and build a pipeline of novel new products to address other needs that are significantly unmet in the eye-care market.Great for investors seeking passive incomeThanks to strong business performance, AbbVie has been able to boost its dividend at an impressive clip.ABBV Dividend data by YCharts.AbbVie has increased its dividend payout each year since its spinoff from Abbott Laboratories was completed in 2013, and the company has raised its payout more than 250% across that stretch. The stock already sports a chunky 4% dividend yield, but based on the pharma giant's payout growth history, there's a good chance investors will actually generate substantially more than the roughly $2,000 in passive income across a five-year stretch with a $10,000 initial investment at today's prices.Based on the current yield, reinvesting your dividends would net you an extra 2.8 shares of AbbVie by next year if you bought $10,000 in stock today -- even if the company opted to break its payout growth streak. From there, those new shares added would also generate dividend payments, setting up a compounding effect. Combined with the potential for capital appreciation, rolling the dividend payments over to reinvest in the stock presents another way investors could wind up generating significantly more than $2,000 from AbbVie's dividend over the next five years.","news_type":1,"symbols_score_info":{"ARKIU":1}},"isVote":1,"tweetType":1,"viewCount":2177,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9036945397,"gmtCreate":1646970595420,"gmtModify":1676534183280,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9036945397","repostId":"1195233805","repostType":4,"repost":{"id":"1195233805","kind":"news","pubTimestamp":1646960442,"share":"https://ttm.financial/m/news/1195233805?lang=&edition=fundamental","pubTime":"2022-03-11 09:00","market":"us","language":"en","title":"7 Cathie Wood Stocks That Are Worth Buying in March","url":"https://stock-news.laohu8.com/highlight/detail?id=1195233805","media":"InvestorPlace","summary":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK In","content":"<div>\n<p>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...</p>\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 Cathie Wood Stocks That Are Worth Buying in March</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 Cathie Wood Stocks That Are Worth Buying in March\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-11 09:00 GMT+8 <a href=https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These ...</p>\n\n<a href=\"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","SPOT":"Spotify Technology S.A.","U":"Unity Software Inc.","PATH":"UiPath","ROKU":"Roku Inc","VRTX":"福泰制药","MELI":"MercadoLibre"},"source_url":"https://investorplace.com/2022/03/7-cathie-wood-stocks-that-are-worth-buying-in-march/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1195233805","content_text":"ARK Invest exchange-traded funds launched by Cathie Wood, CEO and chief investment officer of ARK Investment Management, made the headlines in 2020 due to their stellar performance that year. These funds typically focus on disruptive technologies or themes that are likely to become part of high-growth stories over the next decade. And as a part of the success of these funds, so-called “Cathie Wood stocks” came to fruition.However, ARK Invest ETFs were hit hard in the past year. Investor rotation from growth into value stocks crushed the overstretched valuations of many of these holdings. Now, Wall Street debates whether theseCathie Woodstocks offer buy-and-hold investors attractive entry points. Given the significant declines, they could potentially offer significant upside.For instance, Cathie Wood’s flagship fund, the ARK Innovation ETF (NYSEARCA:ARKK), significantly underperformed the Nasdaq 100 in 2021. It ended the year down more than 23%; whereas, the Nasdaq gained 26%. In addition, ARKK is down almost40% year-to-date (YTD) compared to Nasdaq’s20% decline over the same period.Against this backdrop, here are seven Cathie Wood stocks worth buying in March:Mercadolibre(NASDAQ:MELI)Roku(NASDAQ:ROKU)Spotify Technology(NYSE:SPOT)Teladoc Health(NYSE:TDOC)UiPath(NYSE:PATH)Unity Software(NYSE:U)Vertex Pharmaceuticals(NASDAQ:VRTX)Cathie Wood Stocks: Mercadolibre(MELI)Our first stock is Mercadolibre, held in the ARK Next Generation Internet ETF(NYSEARCA:ARKW). Argentina-based Mercadolibre is an e-commerce giant with a network of roughly 132 million active buyers and 1 million sellers in Latin America. The region is widely regarded as the fastest-growing e-commerce region worldwide, with an e-commerce penetration level of only 10% expected by 2025.Mercadolibreissued Q4 2021 results on Feb. 22. Revenuessurged74% year-over-year (YOY)on a currency-neutral basis to $2.1 billion. Yet, due to higher operating expenses and foreign currency losses, its net loss came in at $46.1 million, or a loss of 92 cents per diluted share. In the previous-year quarter, the net loss was $50.6 million. Cash and equivalents ended the period at $2.5 billion.Unique active users across the e-commerce platform jumped from 78.7 million to 82.2 million during the quarter.As a result, fintech revenue saw a YOY increase of 70%, accounting for 37% of total revenue. In addition, Total Payment Volume (TPV)on its Mercado Pago payment platform increased to $24 billion, meaning YOY growth of 73%.MELI stock hovers around $900, down 32% YTD. Shares are trading at a steep discount at 6.75 times trailing sales, the lowest since 2016. According toCNN Business, the 12-month median price forecast for MELI stock stands at $1,600.Roku(ROKU)Our next stock isRoku, held in the ARKK fund. San Jose, California-based Roku offers an operating platform serving as a hub for thousands of streaming services. The company generates revenue from advertising, hardware sales, subscription sales, distribution fees and operating system (OS) licensing.Management announcedQ4 2021 results on Feb. 17. Revenues grew 33% YOY to $865 million.Yet, net income declined to $23.7 million, or 17 cents per diluted share. In the previous-year quarter, net income was$67.3 million. Cash and equivalents ended the period at $2.1 billion.Roku gained 8.9 million active accounts in 2021to reach 60.1 million. Roku’s total number of active accounts stateside has recently exceeded total subscribers to all U.S. cable companies combined. The average revenue per user came in at $41.03, up 43% YOY.Businesses are increasingly using Roku’s digital platform to reach a wider audience. Management anticipates a revenue increase of roughly 25% for the current quarter.ROKU stock is around $110, down 52% YTD. Shares are currently trading at5.8 times trailing sales. Meanwhile, the 12-month median price forecast for Roku stock is at $180.Cathie Wood Stocks: Spotify Technology(SPOT)Next up is Spotify, also held in the ARKK fund. The Sweden-based Spotify is the leading audio streaming service and media services provider. Its platform serves 406 million monthly active users and 180 million premium subscribers. The streaming company generates revenue from its premium ad-free service and ad-supported access to music and podcasts.Spotify released Q4 2021 results on Feb. 2. Revenue grew 24% YOY to2.69billion euros. Net loss narrowed to 39 million euros, or 21 euro cents per diluted share, down from 125 million euros in the prior-year quarter. Cash and equivalents ended the period at 3.6 billion euros.The advertising business, which now accounts for 15% of its total revenue, grew 40% YOY in Q4. The rapid growth was primarily due to the recent launch of the Spotify Audience Network (SPAN), a dynamic advertising marketplace for both music and podcasts. The growing popularity of podcasts could provide significant upside potentialtoSpotify’s non-music advertising business.SPOT stock hit a 52-week low of$125.84 on Mar. 8, but managed to bounce off that low to close at $131.68. Nevertheless, it is still down 45% YTD.Considering the shares are trading at a cheap 2.4 times trailing sales, this recent selloff offers an attractive buying opportunity for long-term investors. The 12-month median price forecast for Spotifystands at$247.84.Teladoc Health(TDOC)Continuing with our list is Teladoc Health, held in the ARK Genomic Revolution ETF(BATS:ARKG). The telehealth platform allows its clients to receive 24-hour, on-demand virtual medical care.Last month, the company announced a new partnership with Amazon (NASDAQ:AMZN) to launchTeladoc on Alexa, Amazon’s digital assistant. The collaboration makes Teladoc’s services more accessible on supported Echo devices.Teladocannounced Q4 2021 results on Feb. 22. Revenue grew 45% YOY to $554 million, which helped its net loss to shrink to $11 million, or 7 cents per share. In the prior-year quarter, the net loss was$394 million. Cash and equivalents ended the period with $894 million.The total number of visits soared 38% YOY in 2021, reaching 15.3 million at the end of the year. Moreover, the average revenue per paid subscriber grew 52% YOY to $2.49. Management expects to grow its revenue at a compound annual rate of 25% through 2024.TDOC stock is at $60 territory, down 67% over the past year and 35% YTD. Shares are trading at 4.9 times trailing sales. The 12-month median price forecast for Teladoc is at $100.Cathie Wood Stocks: UiPath(PATH)Moving on, the next Cathie Wood stock to consider is UiPath, which is held in the ARK Fintech Innovation ETF(NYSEARCA:ARKF). It provides robotic process automation (RPA)solutions. Gartner and IDC both named UiPath a market leader in using artificial intelligence (AI) to automate enterprise workflows.The company develops UiPath Studio, a platform designed for RPA developers looking to build complex process automations with built-in governance capabilities.Uipath released Q3 FY22 results on Dec. 8. Revenue increased 50% YOY to $221 million. However, the company reported a net loss of $122.8 million, or 23 cents per diluted share, up from a loss of $70.8 million a year ago. Cash and equivalents ended the period at $1.8 billion.Investors were pleased that the company delivered 58% annualized renewal run-rate growth in Q4. Existing clients spent 42% more on UiPath’s services than they did in the prior-year period as well.PATH stock hit a 52-week low of $26.96 on Mar. 7. It’s down 36% YTD. Shares are trading at 17.6 times trailing sales, compared to 60 times last year. The 12-month median price forecast for Uipathstands at $57.50.Cathie Wood Stocks: Unity Software(U)Our penultimate stock is Unity Software, held in the ARKK fund. The San Francisco, California-based Unity Software provides a platform to create interactive and real-time 2D and 3D content. Many popular games in the video game industry rely on its Unity gaming engine.Management reportedQ4 2021 results on Feb. 3. Revenue increased 43% YOY to $316 million. Non-GAAP loss declined to $12 million, or 5 cents lost per share, down from $20.1 million. Cash and equivalents ended the quarter at $1.1 billion.Unity Software continues to benefit from the growing demand for real-time 3D content across various industries outside of video gaming. Automotive, aerospace and defense (A&D), architecture, engineering sectors have all witnessed increased adoption of the Unity engine.Moreover, the emerging metaverse provides Unity with the perfect tailwind for further growth. As a result, the company anticipates an increase in its revenues of35% YOY to $1.5 billion in 2022.Unity currently trades around $80, down about 40% YTD. Shares are trading at 20.8 times trailing sales, down from 40 last year. Meanwhile, the 12-month median price forecast for Unity stock is at $157.50.Cathie Wood Stocks: Vertex Pharmaceuticals(VRTX)The final stock isVertex Pharmaceuticals, found in the ARKG fund. The Boston, Massachusetts-based biotech name focuses on discovering and developing small-molecule medicines to treat serious diseases.For instance, in treating cystic fibrosis (CF), Vertex enjoys a monopoly. It has various drugs for treating different genetic mutations.Vertex announced Q4 2021 results on Jan. 26. Revenue increased 27% YOY to $2.1 billion. Non-GAAP net income came in at $866 million, or $3.37 per diluted share, up from $661 million in the prior-year quarter. Cash and equivalents ended the period at $7.5 billion.The new next-generation combination drug Trikaftadrove the top line growth in 2021. The drug is slated to help 90% of CF patients, a considerable step up from previous generation drugs. Currently, the company’s treatments are used by roughly half of the patients in the U.S., Canada, Europe and Australia. In addition, the company recently partnered with CRISPR Therapeutics(NASDAQ:CRSP) to develop a gene-editing therapy against beta-thalassemia and sickle cell disease.VRTX stock currently hovers around $235, up 11% over the past year. Shares are trading at 16.1 times forward earnings and 8.1 times trailing sales. The 12-month median price forecast for Vertex stock stands at $275.","news_type":1,"symbols_score_info":{"U":0.9,"SPOT":0.9,"ROKU":0.9,"PATH":0.9,"VRTX":0.9,"TDOC":0.9,"MELI":0.9}},"isVote":1,"tweetType":1,"viewCount":2479,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092351744,"gmtCreate":1644541773297,"gmtModify":1676533938850,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092351744","repostId":"2210187875","repostType":4,"repost":{"id":"2210187875","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1644532585,"share":"https://ttm.financial/m/news/2210187875?lang=&edition=fundamental","pubTime":"2022-02-11 06:36","market":"us","language":"en","title":"Wall Street Ends down Sharply on Fears of Aggressive Fed Rate Hikes","url":"https://stock-news.laohu8.com/highlight/detail?id=2210187875","media":"Reuters","summary":"* CPI rose 7.5% in January, above estimates* Bullard \"dramatically\" more hawkish* Disney jumps on upbeat quarterly results* Indexes: Dow -1.47%, S&P 500 -1.81%, Nasdaq -2.10%Feb 10 (Reuters) - Wall St","content":"<html><head></head><body><p>* CPI rose 7.5% in January, above estimates</p><p>* Bullard "dramatically" more hawkish</p><p>* Disney jumps on upbeat quarterly results</p><p>* Indexes: Dow -1.47%, S&P 500 -1.81%, Nasdaq -2.10%</p><p>Feb 10 (Reuters) - Wall Street ended sharply lower on Thursday after U.S. consumer prices data came in hotter than expected and subsequent comments from a Federal Reserve official raised fears the U.S. central bank will hike rates aggressively to fight inflation.</p><p>U.S. Labor Department data showed consumer prices surged 7.5% last month on a year-over-year basis, topping economists' estimates of 7.3% and marking the biggest annual increase in inflation in 40 years.</p><p>U.S. stocks fell further after St. Louis Federal Reserve Bank President James Bullard said the data had made him "dramatically" more hawkish. Bullard, a voting member of the Fed's rate-setting committee this year, said he now wanted a full percentage point of interest rate hikes by July 1.</p><p>"Inflation tends to be kryptonite to valuations. Higher inflation causes multiples to compress, and that's what we're experiencing right now," said Terry Sandven, chief equity strategist at U.S. Bank Wealth Management in Minneapolis.</p><p>"Volatility is likely to remain until in the number and magnitude of Fed rate hikes is better known."</p><p>Within minutes of Bullard comments, rate futures contracts were fully pricing an increase in the Fed's target range for its policy rate to 1%-1.25% by the end of its policy meeting in June, with some bets on an even steeper rate hike path.</p><p>Megacap growth stocks Tesla Inc, Nvidia and Microsoft each lost around 3%.</p><p>The Dow Jones Industrial Average fell 1.47% to end at 35,241.59 points, while the S&P 500 lost 1.81% to 4,504.06.</p><p>The Nasdaq Composite dropped 2.1% to 14,185.64. It was the seventh time in 2022 that the Nasdaq lost more than 2% in a session.</p><p>The S&P 500 is now down about 5% in 2022, and the Nasdaq is down about 9%.</p><p>All of the 11 S&P 500 sector indexes declined, with technology, down 2.75%, and real estate, down 2.86%, leading the way lower.</p><p>Meanwhile, U.S. companies continued to report upbeat quarterly results. With 78% of the S&P 500 companies that have reported results beating analysts' profit estimates, according to Refinitiv data.</p><p>Walt Disney Co rose 3.4% after beating revenue and profit estimates on strong subscriber additions and attendance at U.S. theme parks.</p><p>Barbie maker Mattel Inc and cereal maker Kellogg Co gained 7.65% and 3.11%, respectively, after forecasting full-year profits above market expectations.</p><p>Thursday's session was busy. Volume on U.S. exchanges was 12.8 billion shares, compared with a 12.5 billion average over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 3.08-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored decliners.</p><p>The S&P 500 posted 31 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 102 new lows.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street Ends down Sharply on Fears of Aggressive Fed Rate Hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street Ends down Sharply on Fears of Aggressive Fed Rate Hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-02-11 06:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* CPI rose 7.5% in January, above estimates</p><p>* Bullard "dramatically" more hawkish</p><p>* Disney jumps on upbeat quarterly results</p><p>* Indexes: Dow -1.47%, S&P 500 -1.81%, Nasdaq -2.10%</p><p>Feb 10 (Reuters) - Wall Street ended sharply lower on Thursday after U.S. consumer prices data came in hotter than expected and subsequent comments from a Federal Reserve official raised fears the U.S. central bank will hike rates aggressively to fight inflation.</p><p>U.S. Labor Department data showed consumer prices surged 7.5% last month on a year-over-year basis, topping economists' estimates of 7.3% and marking the biggest annual increase in inflation in 40 years.</p><p>U.S. stocks fell further after St. Louis Federal Reserve Bank President James Bullard said the data had made him "dramatically" more hawkish. Bullard, a voting member of the Fed's rate-setting committee this year, said he now wanted a full percentage point of interest rate hikes by July 1.</p><p>"Inflation tends to be kryptonite to valuations. Higher inflation causes multiples to compress, and that's what we're experiencing right now," said Terry Sandven, chief equity strategist at U.S. Bank Wealth Management in Minneapolis.</p><p>"Volatility is likely to remain until in the number and magnitude of Fed rate hikes is better known."</p><p>Within minutes of Bullard comments, rate futures contracts were fully pricing an increase in the Fed's target range for its policy rate to 1%-1.25% by the end of its policy meeting in June, with some bets on an even steeper rate hike path.</p><p>Megacap growth stocks Tesla Inc, Nvidia and Microsoft each lost around 3%.</p><p>The Dow Jones Industrial Average fell 1.47% to end at 35,241.59 points, while the S&P 500 lost 1.81% to 4,504.06.</p><p>The Nasdaq Composite dropped 2.1% to 14,185.64. It was the seventh time in 2022 that the Nasdaq lost more than 2% in a session.</p><p>The S&P 500 is now down about 5% in 2022, and the Nasdaq is down about 9%.</p><p>All of the 11 S&P 500 sector indexes declined, with technology, down 2.75%, and real estate, down 2.86%, leading the way lower.</p><p>Meanwhile, U.S. companies continued to report upbeat quarterly results. With 78% of the S&P 500 companies that have reported results beating analysts' profit estimates, according to Refinitiv data.</p><p>Walt Disney Co rose 3.4% after beating revenue and profit estimates on strong subscriber additions and attendance at U.S. theme parks.</p><p>Barbie maker Mattel Inc and cereal maker Kellogg Co gained 7.65% and 3.11%, respectively, after forecasting full-year profits above market expectations.</p><p>Thursday's session was busy. Volume on U.S. exchanges was 12.8 billion shares, compared with a 12.5 billion average over the last 20 trading days.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 3.08-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored decliners.</p><p>The S&P 500 posted 31 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 102 new lows.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","BK4504":"桥水持仓","BK4559":"巴菲特持仓","BK4550":"红杉资本持仓","BK4548":"巴美列捷福持仓","MAT":"美国美泰公司","DIS":"迪士尼","BK4551":"寇图资本持仓","BK4527":"明星科技股",".DJI":"道琼斯","BK4099":"汽车制造商","MSFT":"微软","K":"家乐氏","BK4534":"瑞士信贷持仓",".IXIC":"NASDAQ Composite","BK4555":"新能源车","BK4533":"AQR资本管理(全球第二大对冲基金)",".SPX":"S&P 500 Index","SPY":"标普500ETF","NVDA":"英伟达","BK4190":"消闲用品","BK4212":"包装食品与肉类"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2210187875","content_text":"* CPI rose 7.5% in January, above estimates* Bullard \"dramatically\" more hawkish* Disney jumps on upbeat quarterly results* Indexes: Dow -1.47%, S&P 500 -1.81%, Nasdaq -2.10%Feb 10 (Reuters) - Wall Street ended sharply lower on Thursday after U.S. consumer prices data came in hotter than expected and subsequent comments from a Federal Reserve official raised fears the U.S. central bank will hike rates aggressively to fight inflation.U.S. Labor Department data showed consumer prices surged 7.5% last month on a year-over-year basis, topping economists' estimates of 7.3% and marking the biggest annual increase in inflation in 40 years.U.S. stocks fell further after St. Louis Federal Reserve Bank President James Bullard said the data had made him \"dramatically\" more hawkish. Bullard, a voting member of the Fed's rate-setting committee this year, said he now wanted a full percentage point of interest rate hikes by July 1.\"Inflation tends to be kryptonite to valuations. Higher inflation causes multiples to compress, and that's what we're experiencing right now,\" said Terry Sandven, chief equity strategist at U.S. Bank Wealth Management in Minneapolis.\"Volatility is likely to remain until in the number and magnitude of Fed rate hikes is better known.\"Within minutes of Bullard comments, rate futures contracts were fully pricing an increase in the Fed's target range for its policy rate to 1%-1.25% by the end of its policy meeting in June, with some bets on an even steeper rate hike path.Megacap growth stocks Tesla Inc, Nvidia and Microsoft each lost around 3%.The Dow Jones Industrial Average fell 1.47% to end at 35,241.59 points, while the S&P 500 lost 1.81% to 4,504.06.The Nasdaq Composite dropped 2.1% to 14,185.64. It was the seventh time in 2022 that the Nasdaq lost more than 2% in a session.The S&P 500 is now down about 5% in 2022, and the Nasdaq is down about 9%.All of the 11 S&P 500 sector indexes declined, with technology, down 2.75%, and real estate, down 2.86%, leading the way lower.Meanwhile, U.S. companies continued to report upbeat quarterly results. With 78% of the S&P 500 companies that have reported results beating analysts' profit estimates, according to Refinitiv data.Walt Disney Co rose 3.4% after beating revenue and profit estimates on strong subscriber additions and attendance at U.S. theme parks.Barbie maker Mattel Inc and cereal maker Kellogg Co gained 7.65% and 3.11%, respectively, after forecasting full-year profits above market expectations.Thursday's session was busy. Volume on U.S. exchanges was 12.8 billion shares, compared with a 12.5 billion average over the last 20 trading days.Declining issues outnumbered advancing ones on the NYSE by a 3.08-to-1 ratio; on Nasdaq, a 2.26-to-1 ratio favored decliners.The S&P 500 posted 31 new 52-week highs and 4 new lows; the Nasdaq Composite recorded 55 new highs and 102 new lows.","news_type":1,"symbols_score_info":{"MAT":0.9,"MSFT":0.9,".IXIC":0.9,"NVDA":0.9,".DJI":0.9,"SPY":0.6,"NQmain":0.9,"K":0.9,"DIS":0.9,"TSLA":0.9,".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2456,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9096742056,"gmtCreate":1644471581037,"gmtModify":1676533931160,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9096742056","repostId":"2210556631","repostType":4,"repost":{"id":"2210556631","kind":"highlight","pubTimestamp":1644455674,"share":"https://ttm.financial/m/news/2210556631?lang=&edition=fundamental","pubTime":"2022-02-10 09:14","market":"us","language":"en","title":"Want 140% to 225% Gains? 2 Growth Stocks to Buy, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2210556631","media":"Motley Fool","summary":"Despite a difficult macroeconomic environment, some analysts are bullish on these growth stocks.","content":"<div>\n<p>Despite the recent sell-off, the S&P 500 is still up 18% over the past year, outpacing its own long-term average of 8% annualized growth. Even so, some Wall Street analysts see plenty of upside left ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/09/want-140-to-225-gains-2-growth-stocks-to-buy/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want 140% to 225% Gains? 2 Growth Stocks to Buy, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant 140% to 225% Gains? 2 Growth Stocks to Buy, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-02-10 09:14 GMT+8 <a href=https://www.fool.com/investing/2022/02/09/want-140-to-225-gains-2-growth-stocks-to-buy/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Despite the recent sell-off, the S&P 500 is still up 18% over the past year, outpacing its own long-term average of 8% annualized growth. Even so, some Wall Street analysts see plenty of upside left ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/02/09/want-140-to-225-gains-2-growth-stocks-to-buy/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4554":"元宇宙及AR概念","BK4555":"新能源车","SNAP":"Snap Inc","BK4099":"汽车制造商","TSLA":"特斯拉","BK4543":"AI","BK4548":"巴美列捷福持仓","BK4077":"互动媒体与服务","BK4551":"寇图资本持仓","BK4527":"明星科技股","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4213":"石油与天然气的勘探与生产","BK4528":"SaaS概念","BK4550":"红杉资本持仓","BK4508":"社交媒体","BK4023":"应用软件","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2022/02/09/want-140-to-225-gains-2-growth-stocks-to-buy/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2210556631","content_text":"Despite the recent sell-off, the S&P 500 is still up 18% over the past year, outpacing its own long-term average of 8% annualized growth. Even so, some Wall Street analysts see plenty of upside left in the market, particularly when it comes to growth stocks, many of which have fallen sharply over the last few months.For instance, Ark Invest currently has a price target of $3,000 on Tesla (NASDAQ:TSLA), implying 225% upside by 2025. And Credit Suisse raised its price target on Snap (NASDAQ:SNAP) to $93 after a strong fourth quarter, implying 140% upside in the next 12 months. Given the potential gains, is it time to add these growth stocks to your portfolio?Let's take a closer look.Image source: Tesla1. TeslaSemiconductor shortages weighed on the auto industry in 2021, but Tesla turned in another impressive performance. For the fourth consecutive year, it ranked as the world's leading electric vehicle (EV) brand, holding 14.4% market share. And the company grew its deliveries by 87%, outpacing all other high-volume manufacturers for the thirteenth consecutive quarter.Perhaps more important, Tesla's efforts to make manufacturing more efficient -- boosting production in California and China, single-piece casting for the Model Y -- are paying off. In the third quarter, the company posted an industry-leading operating margin of 14.6%, and that figure ticked up to 14.7% in the fourth quarter. Additionally, the cost of goods per vehicle dropped to $36,000 in the fourth quarter, down from $38,000 in the first quarter and $84,000 in 2017.For the full year, Tesla's revenue skyrocketed 71% to $53.8 billion, and the company posted a GAAP profit of $2.05 per diluted share -- in fact, the company has now achieved GAAP profitability for the last 10 consecutive quarters. And free cash flow jumped 49% to $2.8 billion. More importantly, the future looks bright for Tesla, as the company believes it can grow EV deliveries at least 50% per year over a multi-year horizon. And output should improve in 2022 as the new Gigafactories in Berlin and Texas start producing vehicles.Perhaps more exciting, CEO Elon Musk noted that Tesla's full self-driving software would eventually be its greatest source of profitability, and he also said the company would \"achieve full self-driving this year.\" If that does indeed come to pass, Tesla would able to launch an autonomous ride-sharing platform, pioneering a market that ARK Invest values at $1.2 trillion by 2030.Also noteworthy, Musk said Tesla's AI-powered humanoid robot (Optimus) may enter production in 2023 -- along with the Cybertruck and Semi -- and that Optimus could eventually be bigger than Tesla's automotive business.So could Tesla reach $3,000 per share by 2025? Well, that would put its market cap at $3 trillion, which is no small task. But if Tesla continues to execute on EV production, while also delivering on its promise of an autonomous ride-sharing service, I think it could hit that price target. But even if that doesn't happen, Tesla still looks like a good stock to hold for the long term.Image source: Getty Images.2. SnapSnap is a camera company that specializes in augmented reality (AR) and artificial intelligence (AI). Its core product is Snapchat, a social platform designed for visual communication. Specifically, people can personalize photos and videos with AR lenses -- tools that add 3D objects and special effects -- then share that content with friends, families, and the broader Snapchat community.Snap's camera also supports scanning, a feature that leans on AI to understand what the camera sees in the viewfinder. For instance, you can scan a car to learn more about the make and model, or you could scan a household product to purchase it on Amazon's marketplace. In short, Snap uses AR and AI to create an engaging social experience, and that strategy has made the mobile app particularly popular with younger generations.In fact, 75% of 13-to-34-year-olds in the United States use Snapchat, and the same is true in geographies like the United Kingdom, France, and Australia. That demographic is particularly valuable to advertisers, as it gives them a chance to build long-lasting customer relationships. To that end, Snap monetizes its business by helping brands build, measure, and optimize targeted ad campaigns.For the full year, the company delivered impressive financial results. Revenue soared 64% to $4.1 billion, and while Snap is still unprofitable on a GAAP basis, the loss narrowed to $488 million in 2021. Better yet, the company posted free cash flow of $223 million, marking the first time Snap has generated positive free cash flow on a full-year basis.So could Snap hit $93 per share in the next 12 months? It's certainly possible, assuming the company continues to execute and Wall Street reacquires its taste for richly valued growth stocks. But even if that doesn't happen, I think this stock looks like a smart long-term investment, as it taps into high-growth industries like digital advertising and the metaverse.","news_type":1,"symbols_score_info":{"TSLA":0,"SNAP":0}},"isVote":1,"tweetType":1,"viewCount":2496,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9098622963,"gmtCreate":1644118341194,"gmtModify":1676533892007,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9098622963","repostId":"2209347958","repostType":4,"isVote":1,"tweetType":1,"viewCount":2925,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9002947025,"gmtCreate":1641905165282,"gmtModify":1676533660262,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9002947025","repostId":"1116218537","repostType":4,"repost":{"id":"1116218537","kind":"news","pubTimestamp":1641904902,"share":"https://ttm.financial/m/news/1116218537?lang=&edition=fundamental","pubTime":"2022-01-11 20:41","market":"us","language":"en","title":"10 Biggest Price Target Changes For Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1116218537","media":"Benzinga","summary":"Keybanc cut the price target for Netflix, Inc. from $725 to $620. Netflix shares rose 0.3% to $541.5","content":"<div>\n<p>Keybanc cut the price target for Netflix, Inc. from $725 to $620. Netflix shares rose 0.3% to $541.58 in pre-market trading.SVB Leerink raised Illumina, Inc. price target from $420 to $430. Illumina ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/22/01/24991678/10-biggest-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Biggest Price Target Changes For Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Biggest Price Target Changes For Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-11 20:41 GMT+8 <a href=https://www.benzinga.com/analyst-ratings/price-target/22/01/24991678/10-biggest-price-target-changes-for-tuesday><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Keybanc cut the price target for Netflix, Inc. from $725 to $620. Netflix shares rose 0.3% to $541.58 in pre-market trading.SVB Leerink raised Illumina, Inc. price target from $420 to $430. Illumina ...</p>\n\n<a href=\"https://www.benzinga.com/analyst-ratings/price-target/22/01/24991678/10-biggest-price-target-changes-for-tuesday\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NFLX":"奈飞","IBM":"IBM","LULU":"lululemon athletica","ILMN":"Illumina","ANF":"爱芬奇","ROKU":"Roku Inc","ACCD":"Accolade, Inc.","LAC":"Lithium Americas Corp.","AAL":"美国航空","NTRS":"北方信托公司"},"source_url":"https://www.benzinga.com/analyst-ratings/price-target/22/01/24991678/10-biggest-price-target-changes-for-tuesday","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1116218537","content_text":"Keybanc cut the price target for Netflix, Inc. from $725 to $620. Netflix shares rose 0.3% to $541.58 in pre-market trading.SVB Leerink raised Illumina, Inc. price target from $420 to $430. Illumina shares rose 3.8% to $375.97 in pre-market trading.Telsey Advisory Group lowered the price target on Lululemon Athletica Inc. from $515 to $470. Lululemon Athletica shares rose 1% to $351.99 in pre-market trading.Keefe, Bruyette & Woods boosted the price target for Northern Trust Corporation from $130 to $152. Northern Trust shares rose 0.8% to $130.30 in pre-market trading.UBS cut International Business Machines Corporation price target from $136 to $124. IBM shares dropped 2.6% to $131.53 in pre-market trading.Morgan Stanley cut American Airlines Group Inc. price target from $23 to $21. American Airlines shares rose 1.4% to $19.06 in pre-market trading.Telsey Advisory Group reduced the price target on Abercrombie & Fitch Co. from $55 to $45. Abercrombie & Fitch shares gained 3.6% to $33.52 in pre-market trading.Keybanc cut the price target on Roku, Inc. from $430 to $325. Roku shares rose 0.6% to $183.96 in pre-market trading.Needham lowered Accolade, Inc. price target from $56 to $33. Accolade shares jumped 10.4% to $21.13 in pre-market trading.Piper Sandler lifted Lithium Americas Corp. price target from $32 to $41. Lithium Americas shares rose 4.6% to $28.00 in pre-market tradin","news_type":1,"symbols_score_info":{"ILMN":0.9,"AAL":0.9,"LULU":0.9,"NFLX":0.9,"LAC":0.9,"ACCD":0.9,"NTRS":0.9,"IBM":0.9,"ANF":0.9,"ROKU":0.9}},"isVote":1,"tweetType":1,"viewCount":2816,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9006561965,"gmtCreate":1641786484993,"gmtModify":1676533648170,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9006561965","repostId":"1139273038","repostType":2,"repost":{"id":"1139273038","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1641784468,"share":"https://ttm.financial/m/news/1139273038?lang=&edition=fundamental","pubTime":"2022-01-10 11:14","market":"us","language":"en","title":"TSM Q4 Earnings Preview: Q4 Sales Seen Up 21%","url":"https://stock-news.laohu8.com/highlight/detail?id=1139273038","media":"Tiger Newspress","summary":"Taiwan Semiconductor Manufacturing (TSM), the world's largest chip foundry will report its results f","content":"<html><head></head><body><p>Taiwan Semiconductor Manufacturing (TSM), the world's largest chip foundry will report its results for the full fourth quarter on Thursday.</p><p>The semiconductor shortage has been a huge story on Wall Street over the last year since it touches so many industries.</p><p>Analysts expect the contract chipmaker to earn $1.12 per U.S. share on sales of $15.64 billion in Q4. That would translate to year-over-year growth of 13% in earnings and 21% in sales. TSM stock has formed a saucer base with a buy point of 142.29.</p><p>Executives said in October that Q4 sales should land between $15.4 billion and $15.7 billion, and that 23% spike would imply progress at boosting production volumes. Investors are hopeful that this rebound also comes with significant price increases that reflect TWSC's leadership position.</p><p>Looking ahead, the company should benefit from strong demand for tech products through 2022. Watch for those trends to support a bullish outlook for 2022, and for the current fiscal quarter -- assuming TWSC isn't facing any major input shortages or production bottlenecks.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSM Q4 Earnings Preview: Q4 Sales Seen Up 21%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSM Q4 Earnings Preview: Q4 Sales Seen Up 21%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-10 11:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Taiwan Semiconductor Manufacturing (TSM), the world's largest chip foundry will report its results for the full fourth quarter on Thursday.</p><p>The semiconductor shortage has been a huge story on Wall Street over the last year since it touches so many industries.</p><p>Analysts expect the contract chipmaker to earn $1.12 per U.S. share on sales of $15.64 billion in Q4. That would translate to year-over-year growth of 13% in earnings and 21% in sales. TSM stock has formed a saucer base with a buy point of 142.29.</p><p>Executives said in October that Q4 sales should land between $15.4 billion and $15.7 billion, and that 23% spike would imply progress at boosting production volumes. Investors are hopeful that this rebound also comes with significant price increases that reflect TWSC's leadership position.</p><p>Looking ahead, the company should benefit from strong demand for tech products through 2022. Watch for those trends to support a bullish outlook for 2022, and for the current fiscal quarter -- assuming TWSC isn't facing any major input shortages or production bottlenecks.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139273038","content_text":"Taiwan Semiconductor Manufacturing (TSM), the world's largest chip foundry will report its results for the full fourth quarter on Thursday.The semiconductor shortage has been a huge story on Wall Street over the last year since it touches so many industries.Analysts expect the contract chipmaker to earn $1.12 per U.S. share on sales of $15.64 billion in Q4. That would translate to year-over-year growth of 13% in earnings and 21% in sales. TSM stock has formed a saucer base with a buy point of 142.29.Executives said in October that Q4 sales should land between $15.4 billion and $15.7 billion, and that 23% spike would imply progress at boosting production volumes. Investors are hopeful that this rebound also comes with significant price increases that reflect TWSC's leadership position.Looking ahead, the company should benefit from strong demand for tech products through 2022. Watch for those trends to support a bullish outlook for 2022, and for the current fiscal quarter -- assuming TWSC isn't facing any major input shortages or production bottlenecks.","news_type":1,"symbols_score_info":{"TSM":0.9}},"isVote":1,"tweetType":1,"viewCount":3048,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9001090131,"gmtCreate":1641096143168,"gmtModify":1676533572090,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9001090131","repostId":"2200441314","repostType":4,"repost":{"id":"2200441314","kind":"highlight","pubTimestamp":1641085740,"share":"https://ttm.financial/m/news/2200441314?lang=&edition=fundamental","pubTime":"2022-01-02 09:09","market":"us","language":"en","title":"2 No-Brainer Stocks Down 27% to 35% to Buy for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2200441314","media":"Motley Fool","summary":"These hot tech stocks might be a steal at these prices.","content":"<div>\n<p>While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/\">Web Link</a>\n\n</div>\n","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 No-Brainer Stocks Down 27% to 35% to Buy for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 No-Brainer Stocks Down 27% to 35% to Buy for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-01-02 09:09 GMT+8 <a href=https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4548":"巴美列捷福持仓","BK4505":"高瓴资本持仓","TWLO":"Twilio Inc","BK4539":"次新股","BK4551":"寇图资本持仓","BK4097":"系统软件","BK4528":"SaaS概念","BK4116":"互联网服务与基础架构","PATH":"UiPath","BK4561":"索罗斯持仓"},"source_url":"https://www.fool.com/investing/2022/01/01/2-no-brainer-stocks-down-27-to-35-to-buy-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2200441314","content_text":"While the stock market at large is hitting all-time highs, many technology stocks have been getting hammered in 2021. Despite this broad drop in tech companies, many businesses are seeing strong success operationally. The share prices are sinking, but these companies continue to grow their top-line and establish their leadership roles in their respective industries.Both UiPath (NYSE:PATH) and Twilio (NYSE:TWLO) are in this boat. Shares of both tech stocks have fallen 35% and nearly 30%, respectively, despite strong growth across their businesses. With large markets ahead of them, I think today's prices could be optimal buying opportunities to get these innovative stocks at a bargain.Image source: Getty Images.1. UiPath: Bringing AI to the enterpriseWe have all been doing something so tedious and repetitive at work that we wish we could simply have it magically completed. It is, after all, a huge waste of our time because we would rather work on more thought-intensive, engaging work. With artificial intelligence-powered virtual bots, UiPath is turning our wishes into commands.The company offers automation software that can emulate a human by understanding what is on a screen, extracting data, and making critical decisions. However, this software can do it much faster than humans, making 58% fewer mistakes. UiPath uses robotic process automation (RPA) in tandem with humans to make businesses more efficient. With UiPath, real workers are not fired or eliminated but rather freed to work on more critical tasks. UiPath has saved some of its customers millions of hours and dollars, which is why over 9,600 customers use UiPath and are currently spending 44% more than they did one year ago.The stock has not fallen because of bad operational performance. The company has brought in $602.5 million in revenue so far this year, 50% higher than the year-ago period. Shares have taken a downturn because of the major uptick in the company's net loss. In the third quarter, the company lost almost $123 million -- more than the total net loss for the first nine months of 2020. This has been because UiPath has rapidly ramped up its spending on advertising, along with research and development.This is not without good reason, however. The company projects that its addressable market will nearly double to $30 billion by 2024. UiPath is already the industry leader in RPA, according to Gartner's Magic Quadrant, but the company is ramping up spending to make sure its competitors like Automation Anywhere do not overtake them. With the RPA market growing so rapidly over the next few years, UiPath is spending now -- rather successfully -- to obtain brand recognition as the industry begins to explode.Here's the bottom line: UiPath is the leader in a futuristic industry that is expected to grow rapidly over the next few years. With so much investment going toward capturing this growth, along with a dominant product that has caught the eyes of NASA and Alphabet, I think that today's share prices are a gift to long-term investors.2. Twilio: Falling victim to the tech sell-offWith over 250,000 businesses using Twilio, most of us have used its technology without even recognizing it. Anyone who has ever communicated with a food delivery driver or Lyft driver has used Twilio's services unknowingly. The company is helping other enterprises communicate within apps, allowing consumers and businesses to connect easier. These services seem to have grown even more important for Twilio's users as they are now spending 31% more today than they did one year ago with the company.Twilio posted year-over-year revenue growth of 65% in Q3, but some of that came from its acquisitions. Although the company has consistently been able to post impressive organic growth -- something most growth-by-acquisition companies lack. In Q3, the company's revenue improved 38% year over year organically, and it has been able to organically boost its top line by 34% or more year over year for the past nine quarters.Shares have largely been sent downward in 2021, and Twilio's major net losses haven't been helping. The company lost $224 million in Q3, with almost $170 million of that being stock-based compensation. While this might be worrisome today, it is overshadowed by the impressive top-line growth that the company is seeing, both organically and inorganically, in this lucrative market. At 17 times sales, this stock is trading at levels not seen since mid-2020, leaving an opportunistic window for investors.The use of in-app communication will only become more prevalent as the world continues to adopt these habits, and Twilio has been and will likely continue benefiting from it. Twilio's future is bright, which is why I think investors should consider taking advantage of these low stock prices today.","news_type":1,"symbols_score_info":{"PATH":1,"TWLO":1}},"isVote":1,"tweetType":1,"viewCount":3100,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9000444540,"gmtCreate":1640277280735,"gmtModify":1676533514038,"author":{"id":"3573512309350380","authorId":"3573512309350380","name":"SSim","avatar":"https://static.tigerbbs.com/bc347d90f5e5fb868ce6d6c9cf5f4763","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3573512309350380","idStr":"3573512309350380"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9000444540","repostId":"1192623075","repostType":4,"repost":{"id":"1192623075","kind":"news","pubTimestamp":1640269891,"share":"https://ttm.financial/m/news/1192623075?lang=&edition=fundamental","pubTime":"2021-12-23 22:31","market":"us","language":"en","title":"U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19","url":"https://stock-news.laohu8.com/highlight/detail?id=1192623075","media":"SeattleTimes","summary":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another ea","content":"<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.</p>\n<p>The Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.</p>\n<p>As a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.</p>\n<p>The Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.</p>\n<p>Known as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.</p>\n<p>The restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.</p>\n<p>The Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.</p>\n<p>Some experts question whether there will be much of a role for the Merck drug in the U.S.</p>\n<p>“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”</p>\n<p>For now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.</p>\n<p>The FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.</p>\n<p>Federal officials have agreed to purchase enough of the drug to treat 3.1 million people.</p>\n<p>The U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.</p>\n<p>Merck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.</p>","source":"lsy1640271591192","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. adds Merck pill as 2nd easy-to-use drug against COVID-19</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. adds Merck pill as 2nd easy-to-use drug against COVID-19\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 22:31 GMT+8 <a href=https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/><strong>SeattleTimes</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug ...</p>\n\n<a href=\"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","MRK":"默沙东"},"source_url":"https://www.seattletimes.com/business/us-adds-merck-pill-as-2nd-easy-to-use-drug-against-covid-19/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1192623075","content_text":"U.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication to battle the rising tide of omicron infections.\nThe Food and Drug Administration authorization of Merck’s molnupiravir comes one day after the agency cleared a competing drug from Pfizer. That pill, Paxlovid, is likely to become the first-choice treatment against the virus, thanks to its superior benefits and milder side effects.\nAs a result, Merck’s pill is expected to have a smaller role against the pandemic than predicted just a few weeks ago. Its ability to head off severe COVID-19 is much smaller than initially announced and the drug label will warn of serious safety issues, including the potential for birth defects.\nThe Food and Drug Administration authorized Merck’s drug for adults with early symptoms of COVID-19 who face the highest risks of hospitalization, including older people and those with conditions like obesity and heart disease. The U.K. first authorized the pill in early November.\nKnown as molnupiravir, the Merck drug will carry a warning against use during pregnancy. Women of childbearing age should use birth control during treatment and for a few days after while men should use birth control for at least three months after their final dose, the FDA said.\nThe restrictions were expected after an FDA advisory panel only narrowly endorsed the drug last month, warning that its use would have to be strictly tailored to patients who can benefit the most.\nThe Pfizer pill works differently and doesn’t carry the same risks. Additionally, Pfizer’s drug was roughly three times more effective in testing, reducing hospitalization and death by nearly 90% among high-risk patients, compared with 30% for Merck’s.\nSome experts question whether there will be much of a role for the Merck drug in the U.S.\n“To the extent that there’s an ample supply of Pfizer’s pill, I think it won’t be used,” said Dr. Gregory Poland of the Mayo Clinic, referring to the Merck drug. “There would be no reason, given it has less efficacy and a higher risk of side effects.”\nFor now, the FDA decision provides another potential option against the virus that has killed more than 800,000 Americans, even as health officials brace for record-setting cases, hospitalizations and deaths driven by the omicron variant. Antiviral pills, including Merck’s, are expected to be effective against omicron because they don’t target the spike protein where most of the variant’s worrisome mutations reside.\nThe FDA based its decision on results showing nearly 7% of patients taking the drug ended up in the hospital and one died at the end of 30 days. That compared with 10% of patients hospitalized who were taking the placebo and nine deaths.\nFederal officials have agreed to purchase enough of the drug to treat 3.1 million people.\nThe U.S. will pay about $700 for each course of Merck’s drug, which requires patients to take four pills twice a day for five days. A review by Harvard University and King’s College London estimated it costs about $18 to make each 40-pill course of treatment.\nMerck’s drug inserts tiny errors into the coronavirus’ genetic code to slow its reproduction. That genetic effect has raised concerns that the drug could cause mutations in human fetuses and even spur more virulent strains of the virus. But FDA scientists said the variant risk is largely theoretical because people take the drug for such a short period of time.","news_type":1,"symbols_score_info":{"PFE":0.9,"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":3237,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}